Denali Therapeutics Inc. (DNLI): Weighted Average Diluted Shares
172.65M
Year ended 2025-12-31
+11.2%
3-year compound annual growth
+8.9%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 172.65M | +5.0% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 164.47M | +19.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 137.37M | +9.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | 125.53M | +3.3% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | 121.52M | +7.8% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | 112.70M | +17.9% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | 95.61M | +3.2% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | 92.62M | n/a | 2021-02-26, From 2018-01-01 |